scholarly journals N-acetylaminogalactosyl-decorated biodegradable PLGA-TPGS copolymer nanoparticles containing emodin for the active targeting therapy of liver cancer

2018 ◽  
Vol 46 (sup2) ◽  
pp. 260-272 ◽  
Author(s):  
Hao Dong ◽  
Guoyu Wu ◽  
Hong Xu ◽  
Chenghong Zhang ◽  
Jiao Wang ◽  
...  
Keyword(s):  
Liver Cancer ◽  
Active Targeting ◽  
Targeting Therapy

A Framework Nucleic Acid Based Robotic Nanobee for Active Targeting Therapy

2020 ◽  
pp. 2007342
Author(s):  
Taoran Tian ◽  
Dexuan Xiao ◽  
Tao Zhang ◽  
Yanjing Li ◽  
Sirong Shi ◽  
...  
Keyword(s):  
Nucleic Acid ◽  
Active Targeting ◽  
Targeting Therapy

scholarly journals Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy

Drug Delivery ◽  
2019 ◽  
Vol 26 (1) ◽  
pp. 595-603 ◽  
Author(s):  
Xianling Gong ◽  
Yi Zheng ◽  
Guangzhi He ◽  
Kebing Chen ◽  
Xiaowei Zeng ◽  
...  
Keyword(s):  
Liver Cancer ◽  
Cancer Targeting ◽  
Targeting Therapy

scholarly journals Targeting therapy in experimental liver cancer: CA 102, noble bile acid-bound alkylating agent.

1988 ◽  
Vol 3 (3) ◽  
pp. 445-449
Author(s):  
Shunzo Hatono ◽  
Masayasu Okuhira ◽  
Ken Hashimoto ◽  
Akira Yazaki ◽  
Masaharu Yokomoto ◽  
...  
Keyword(s):  
Bile Acid ◽  
Liver Cancer ◽  
Alkylating Agent ◽  
Targeting Therapy ◽  
Experimental Liver

Peptide-Modified Nanoparticles for Tumor Targeting and Molecular Imaging

2020 ◽  
Vol 27 ◽  
Author(s):  
Liejing Lu ◽  
Qinyuan Zhang ◽  
Zhe Wang ◽  
Liqian Gao ◽  
Jun Shen
Keyword(s):  
Molecular Imaging ◽  
Tumor Targeting ◽  
Active Targeting ◽  
Great Promise ◽  
Tumor Site ◽  
Targeting Therapy ◽  
Therapeutic Drugs ◽  
Tumor Tissues ◽  
Peptide Targeting

: Nanoparticles hold great promise in tumor targeting and molecular imaging because they can co-deliver therapeutic drugs and imaging agents to the tumor site with a single entity. Nanoparticles modified with ligands against moieties overexpressed on tumor tissues have gained increasing attention due to their active targeting mechanisms. Peptides are well suited for nanoparticle targeting modifications because they are small, easy to synthesize and typically non-immunogenic. Herein, we review the peptide-modified nanoparticles used for tumor targeting therapy and molecular imaging based on the classification of peptide-targeting ligands. The development of targeting peptides and nanoparticles will also be discussed.

Sign in / Sign up

Export Citation Format

Share Document